XML 13 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Research and development expenses $ 309 $ 413
Selling and Marketing 23 91
General and administrative expenses 564 252
Total operating expenses 896 756
Operating loss 896 756
Financing income (expense), net (8) 22
Loss for the period 904 734
Other comprehensive income:    
Foreign currency translation adjustment 22 19
Comprehensive Loss for the period $ 882 $ 715
Loss per share (Basic and Diluted) $ (0.00) $ (0.00)
Common shares used in computing Basic and Diluted Loss per share 200,781,064 181,790,919